Detailed price information for Vistagen Therapeutics Inc (VTGN-Q) from The Globe and Mail including charting and trades.

Vistagen Therapeutics Inc (VTGN) advances its neuroscience and women's health programs while addressing challenges in clinical trials and regulatory strategies.

New tool leverages proprietary hiring success learning models trained on 150M+ hiring outcomes and proven science ...

Each February, local participants brave the cold to learn more about maple syrup production at an annual workshop at Dixon Springs Ag Center.

The global Claims Processing Software Market was valued at USD 5.2 billion and is projected to reach USD 10.1 billion by 2033. The market is expected to grow at a robust CAGR of 8.5% during the ...

Intrizen, a leading HR + IT transformation company and official SAP Partner, announced the expansion of its executive ...

The government will inject an additional 1.5 billion Singapore dollars, equivalent to US$1.19 billion, to the Financial Sector Development Fund, bringing the total size of the Equity Market ...

AIOps won’t replace your ops team next year — but if you ignore AI-driven prioritization, RCA and automation, you’ll fall ...

Q3 2026 Management View Shawn Singh, President and CEO, highlighted the completion of the randomized portion of the PALISADE-3 Phase III trial in social anxiety disorder as a key milestone, stating ...

Landmark research from Nord Anglia Education reveals how students can develop the skills AI cannot replace.LONDON, Feb. 12, 2026 /PRNewswire/ -- As AI accelerates into classrooms and workplaces ...

SPS Commerce Inc. reports fourth-quarter results after the market close Thursday, with investors watching whether the cloud-based supply chain software provider can extend its growth streak to an ...

MEDDICC, a leading innovator in GTM strategy, today announced the launch of Winni Call Recorder and Opportunity Manager, two new tools designed to help ...